Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation

被引：0

作者：

Chengyu Shi ^{[1
]}

Ying Wang ^{[2
]}

Minjie Wu ^{[3
]}

Yu Chen ^{[1
]}

Fangzhou Liu ^{[2
]}

Zheyuan Shen ^{[3
]}

Yiran Wang ^{[1
]}

Shaofang Xie ^{[2
]}

Yingying Shen ^{[3
]}

Lingjie Sang ^{[1
]}

Zhen Zhang ^{[2
]}

Zerui Gao ^{[3
]}

Luojia Yang ^{[1
]}

Lei Qu ^{[2
]}

Zuozhen Yang ^{[3
]}

Xinyu He ^{[4
]}

Yu Guo ^{[5
]}

Chenghao Pan ^{[1
]}

Jinxin Che ^{[6
]}

Huaiqiang Ju ^{[7
]}

Jian Liu ^{[1
]}

Zhijian Cai ^{[1
]}

Qingfeng Yan ^{[1
]}

Luyang Yu ^{[1
]}

Liangjing Wang ^{[1
]}

Xiaowu Dong ^{[1
]}

Pinglong Xu ^{[1
]}

Jianzhong Shao ^{[5
]}

Yang Liu ^{[4
]}

Xu Li ^{[5
]}

Wenqi Wang ^{[5
]}

Ruhong Zhou ^{[8
]}

Tianhua Zhou ^{[9
]}

Aifu Lin ^{[7
]}

机构：

[1] Zhejiang University,MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences

[2] Zhejiang University,Cancer Center

[3] Key Laboratory for Cell and Gene Engineering of Zhejiang Province,Innovation Institute for Artificial Intelligence in Medicine

[4] Zhejiang University,Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences

[5] Zhejiang University,Key Laboratory of Structural Biology of Zhejiang Province, Westlake Laboratory of Life Sciences and Biomedicine

[6] Westlake University,Institute of Immunology

[7] Zhejiang University School of Medicine,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology

[8] Sun Yat-sen University Cancer Center,MOE Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute

[9] State Key Laboratory of Oncology in South China,Department of Developmental and Cell Biology

[10] Collaborative Innovation Center for Cancer Medicine,Shanghai Institute for Advanced Study

[11] Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute),Department of Chemistry

[12] Zhejiang University School of Medicine,Institute of Quantitative Biology

[13] International Campus,Department of Cell Biology and Program in Molecular Cell Biology

[14] Zhejiang University,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology

[15] Zhejiang University,Breast Center of the First Affiliated Hospital, School of Medicine

[16] Zhejiang University,International School of Medicine, International Institutes of Medicine

[17] University of California,undefined

[18] Zhejiang University,undefined

[19] Colombia University,undefined

[20] Zhejiang University,undefined

[21] Zhejiang University School of Medicine,undefined

[22] Zhejiang University,undefined

[23] Zhejiang University,undefined

[24] The 4th Affiliated Hospital of Zhejiang University School of Medicine,undefined

[25] ZJU-QILU Joint Research Institute,undefined

来源：

Nature Communications | / 15卷 / 1期

关键词：

D O I：

10.1038/s41467-024-55049-5

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
Cui, Xiaopei
Jia, Huifeng
Xin, Hong
Zhang, Lei
Chen, Shi
Xia, Simin
Li, Xue
Xu, Wei
Chen, Xiaofang
Feng, Yujie
Wei, Xiaoyue
Yu, Haijia
Wang, Yanting
Zhan, Yifan
Zhu, Xiangyang
Zhang, Xuemei
FRONTIERS IN IMMUNOLOGY, 2021, 12
[22] Targeting Glutamine Metabolism and PD-L1: A Novel Anti-tumor Pas de Deux
Matias, Maria I.
Dardalhon, Valerie
Taylor, Naomi
MOLECULAR CELL, 2020, 80 (04) : 555 - 557
[23] Bifunctional molecular probe targeting tumor PD-L1 enhances anti-tumor efficacy by promoting ferroptosis in lung cancer mouse model
Shao, Chenxu
Yan, Xiaoping
Pang, Shangjie
Nian, Di
Ren, Li
Li, Hui
Sun, Junjie
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130
[24] Targeting glycosylated PD-1 induces potent anti-tumor immunity
Wang, Yuhan
Sun, Linlin
Yang, Riyao
Liu, Jielin
Qiu, Yufan
Hsu, Jennifer L.
Cha, Jong-ho
Chan, Li-Chuan
Hsu, Jung-Mao
Lee, Heng-Huan
Lai, Yun-Ju
Khoo, Kay-Hooi
Chung, Ezra M.
Li, Chia-Wei
Kim, Yong-Soo
Park, Andrew H.
Yang, Yi
Yoo, Stephen S.
Hung, Mien-Chie
CANCER RESEARCH, 2020, 80 (16)
[25] Pharmacokinetic analysis of anti-PD-1 and PD-L1 antibodies and evaluation of their anti-tumor effects
Hatakeyama, Hiroto
Kurino, Taiki
Matsuda, Reiko
Suzuki, Hiroyuki
Terui, Ayu
Uehara, Tomoya
Arano, Yasushi
Hisaka, Akihiro
CANCER RESEARCH, 2019, 79 (13)
[26] Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells
Wang, Kaifang
Cai, Rong
Fei, Shuting
Chen, Xuzheng
Feng, Sisi
Zhang, Lulu
Liu, Hui
Zhang, Zhiguang
Song, Jun
Zhou, Ruixiang
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2023, 568
[27] Vascular Targeting Viral Therapy Augments Pd-L1 Checkpoint Blockade Anti-Tumor Activity
Breitbart, Eyal
Mendel, Itzhak
Yacov, Niva
MOLECULAR THERAPY, 2017, 25 (05) : 270 - 271
[28] Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Maohua Li
Rongqing Zhao
Jianxin Chen
Wenzhi Tian
Chenxi Xia
Xudong Liu
Yingzi Li
Song Li
Hunter Sun
Tong Shen
Wenlin Ren
Le Sun
Scientific Reports, 12
[29] Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment
Li, Jie
Cao, Peiyu
Chen, Yuxin
Wang, Junqi
Sun, Xiaolei
Chen, Renfu
Wang, Gang
Hou, Jianquan
EXPERIMENTAL CELL RESEARCH, 2022, 417 (01)
[30] Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer
Wang, Wei
Kong, Min
Shen, Fu
Li, Ping
Chen, Cheng
Li, Yueqin
Li, Cheng
Qian, Zhiqiang
Zhong, Aihua
Wang, Yuhua
Yang, Liang
He, Fangkai
Li, Weichun
FRONTIERS IN IMMUNOLOGY, 2024, 15

← 1 2 3 4 5 →